查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1939424

醫藥級PET/PVDC薄膜市場（依材料類型、薄膜形式、厚度、應用和最終用途產業分類），全球預測（2026-2032年）

Pharma-Grade PET/PVDC Film Market by Material Type, Film Form, Thickness, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫藥級 PET/PVDC 薄膜市值將達到 8.9035 億美元，到 2026 年將成長至 9.5925 億美元，到 2032 年將達到 16.1435 億美元，複合年成長率為 8.87%。

關鍵市場統計數據
基準年 2025 8.9035億美元
預計年份：2026年 9.5925億美元
預測年份 2032 16.1435億美元
複合年成長率 (%) 8.87%

本文簡明扼要地策略性地介紹了藥用級PET/PVDC薄膜在保護藥品完整性以及應對監管和供應複雜性方面所發揮的關鍵作用。

醫藥級PET/PVDC薄膜處於先進材料科學與嚴格監管要求的關鍵交匯點。過去十年，製造商和加工商一直在努力平衡可靠的防潮防氧性能與不斷發展的永續永續性期望以及日益嚴格的藥品包裝法規之間的關係。 PET的耐用機械性能與PVDC或其他阻隔塗層的結合對於保護敏感劑型至關重要，但也帶來了複雜的生產、回收和處置問題。因此，產品團隊、採購經理和法規專業人員在選擇薄膜時，不僅要評估即時阻隔性能，還要評估其長期合規性和供應穩定性。

技術創新、日益嚴格的法規和永續性要求如何共同作用，改變阻隔膜應用領域的產品設計、採購和商業化？

醫藥級PET/PVDC薄膜產業正經歷變革性的轉變，這主要得益於技術創新、日益嚴格的監管以及對循環經濟的重新關注。塗層化學和複合技術的進步使得在維持同等甚至更優異阻隔性能的前提下，實現更薄的壁厚結構，從而減少材料用量並提高包裝生產線的產能。同時，全球監管機構對可萃取物和可浸出物的檢驗不斷加大，迫使供應商改進聚合物配方，並在加速老化和滅菌通訊協定下驗證塗層的附著力和遷移特性。這些技術和監管壓力共同推動了混合解決方案的普及，這些方案將傳統的PVDC性能與替代隔離層相結合，以滿足環境和供應鏈方面的特定需求。

了解近期關稅變動對藥品包裝供應商的採購風險、生產分配和監理檢驗負擔的連鎖影響

近期關稅政策的變化和貿易政策的調整，為加工商和藥品包裝產業買家的供應鏈規劃和成本最佳化帶來了新的複雜性。關稅措施影響了區域生產地的相對競爭力，促使籌資策略進行短期調整，即便產品規格是供應商選擇的主要促進因素。由於交易成本波動，製造商在製定供應協議時會考慮包括合規性、運輸前置作業時間和關稅風險在內的總到岸成本。這種情況促使企業尋求多元化採購管道，簽訂包含關稅保護條款的長期採購協議，並加強採購部門和監管部門之間的合作，以確保關鍵藥品包裝規格的持續供應。

透過應用、材料結構、薄膜形態、厚度頻寬和最終用途要求進行深度細分分析，可以確定性能檢驗和商業性適用性。

按應用、材料類型、薄膜規格、厚度和最終用途行業進行市場細分，可以清楚揭示影響材料選擇和生產策略的性能優先級和商業化路徑。按應用評估，泡殼包裝需要穩定的熱成型性和持久的密封完整性，而蓋膜則優先考慮剝離性能和透明無缺陷的表面，以實現防篡改保護。包裝袋需要兼具阻隔性和密封強度的軟性多層結構，且密封劑必須在各種熱封條件下提供可靠的黏合性和氣密性。這些不同的性能要求不僅決定了塗層薄膜與擠出複合薄膜的選擇，還決定了檢驗通訊協定和在線連續品質檢測方法。

深入分析美洲、歐洲、中東和非洲以及亞太地區在阻隔膜製造優先事項、監管重點和永續性預期方面的差異

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的材料供應、合規預期和商業化模式，每個地區都為製造商和加工商呈現出不同的風險回報特徵。在美洲，對生產效率和快速規模化的重視促使企業投資於高產能加工生產線和一體化供應鏈關係。主要市場的法規結構要求提供詳細的品質文件和批次可追溯性，這鼓勵企業建立本地庫存緩衝和戰略夥伴關係，以檢驗供應來源可靠。該地區的物流基礎設施有利於大型契約製造採用準時交貨模式，而貿易政策的波動性可能會促使企業制定區域性雙重緊急時應對計畫。

區分市場領導者的關鍵企業策略和能力投資包括塗料品質體系創新和合作商業化模式。

醫藥級PET/PVDC薄膜生態系統中的主要企業正圍繞著創新、合規性和垂直合作，整合各自的策略。成功的企業不斷投資於塗層研發和複合技術，以提高阻隔性能，同時實現永續性目標。這些投資通常包括建造新型塗層化學試劑的試驗生產線、部署自動化檢測系統以確保快速穩定的質量，以及擴展可萃取物和可浸出物檢測的分析能力。材料供應商和加工商之間的策略夥伴關係正逐漸成為加速產品認證和縮短新包裝概念上市時間的有效途徑。

為採購、研發和監管團隊提供切實可行、影響深遠的建議，以確保供應安全、推動負責任的創新並加速合規商業化。

行業領導者應立即採取可衡量的行動，以確保供應連續性，加速材料創新，並使包裝產品組合與不斷變化的監管和永續性預期保持一致。首先，整合跨職能部門的管治——包括採購、法規事務和研發部門——以對阻隔績效、驗證工作量和供應風險的全面評估為基礎，做出材料選擇決策。這種協作可以縮短決策週期，並降低後期出現可比性問題的可能性。其次，拓展供應商網路，納入區域加工商和特殊塗料製造商，以降低關稅風險和物流中斷的影響，同時能夠快速回應臨床試驗和商業化上市。第三，優先投資分析和中試規模能力，以便在產品開發早期檢驗可萃取物、熱穩定性和滅菌相容性，從而消除意外的下游加工問題。

我們的研究結果透過透明且可複製的調查方法檢驗，該方法結合了面對面的專家訪談、技術文獻綜述和供應鏈映射。

本執行摘要的調查方法有系統地結合了第一手資料和第二手資料，以確保提供切實可行的洞見。第一手資料包括對製藥和醫療設備製造商的包裝工程師、法規事務專家和採購人員進行結構化訪談，以收集有關材料性能、檢驗挑戰和供應商選擇標準的第一手資訊。隨後，將這些洞見與塗層化學家和轉換工程師的技術討論進行交叉比對，以檢驗新型阻隔解決方案的可行性，並確定規模化生產和生產線整合的操作限制。

總之，本次綜合回顧強調，技術、監管和籌資策略的綜合方法對於保護產品完整性和商業性韌性至關重要。

總之，醫藥級PET/PVDC薄膜策略需要在阻隔性能、法規遵循、供應鏈穩定性和環境責任之間取得平衡。雖然塗層和複合技術的創新能夠實現更薄、更有效率的結構，但監管機構對可萃取物和生命週期影響的日益關注，要求進行嚴格的檢驗和記錄。關稅波動使得供應商多元化和區域產能投資成為切實可行的策略，而非可選項。此外，按應用、材料結構、薄膜形態、厚度和最終用途進行細分，可以突出哪些領域的性能投資能夠帶來最大的商業性回報。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依材料類型分類的醫藥級PET/PVDC薄膜市場

  • 塗層膜
    • EVOH塗層
    • PVDC塗層
    • SiOx塗層
  • 擠出複合薄膜
    • 黏合劑層壓
    • 共擠出

9. 依薄膜類型分類的醫藥級PET/PVDC薄膜市場

  • 單頁紙
  • 卷材

10. 醫藥級PET/PVDC薄膜市場（依厚度分類）

  • 60至80微米
  • 80微米或以上
  • 小於60微米

第11章 依應用領域分類的醫藥級PET/PVDC薄膜市場

  • 泡殼包裝
  • 蓋膜
  • 小袋
  • 密封劑

12. 依最終用途產業分類的醫藥級PET/PVDC薄膜市場

  • 醫療設備
  • 營養補充品
  • 製藥
  • 獸藥產品

13. 各地區醫藥級PET/PVDC薄膜市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫藥級PET/PVDC薄膜市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國醫藥級PET/PVDC薄膜市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國醫藥級PET/PVDC薄膜市場

第17章：中國醫藥級PET/PVDC薄膜市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amcor Plc
  • Asahi Kasei Corporation
  • Berry Global Group, Inc.
  • Bilcare Limited
  • Constantia Flexibles Group GmbH
  • Cosmo Films Ltd.
  • DuPont de Nemours, Inc.
  • Honeywell International Inc.
  • Innovia Films Ltd.
  • Jindal Poly Films Limited
  • Jindal Poly Films Limited
  • Klockner Pentaplast Group
  • Kuraray Co., Ltd
  • Kureha Corporation
  • Mitsubishi Chemical Corporation
  • Mondi plc
  • SKC Co., Ltd
  • Toray Plastics, Inc.
Product Code: MRR-9A6A6F29762C

The Pharma-Grade PET/PVDC Film Market was valued at USD 890.35 million in 2025 and is projected to grow to USD 959.25 million in 2026, with a CAGR of 8.87%, reaching USD 1,614.35 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 890.35 million
Estimated Year [2026] USD 959.25 million
Forecast Year [2032] USD 1,614.35 million
CAGR (%) 8.87%

A concise strategic introduction to the critical role of pharma-grade PET/PVDC film in safeguarding drug integrity while navigating regulatory and supply complexities

Pharma-grade PET/PVDC film occupies a pivotal position at the intersection of advanced materials science and stringent regulatory demand. Over the past decade, manufacturers and converters have continuously balanced the need for reliable moisture and oxygen barrier performance with evolving sustainability expectations and ever-tightening pharmaceutical packaging regulations. The durable mechanical properties of PET, coupled with PVDC or alternate barrier coatings, deliver critical protection for sensitive dosage forms, but they also introduce complexity across production, recycling, and end-of-life considerations. Consequently, product teams, procurement leaders, and regulatory affairs professionals must evaluate film selection not only for immediate barrier attributes but also for long-term compliance and supply resiliency.

This introduction frames the essential trade-offs that define strategy in this space. Material selection decisions ripple across primary packaging formats, influence sterilization and stability protocols, and determine compatibility with automated packaging lines. In addition, global supply chain dynamics and tariff adjustments are reshaping procurement risk profiles, prompting a shift toward diversified sourcing and regionalized manufacturing footprints. By establishing this context, stakeholders can better appreciate why a focused, evidence-based approach to barrier film strategy is now essential for protecting drug integrity, maintaining regulatory alignment, and meeting commercial timelines.

How technological advances regulatory scrutiny and sustainability demands are jointly transforming product design sourcing and commercialization in barrier film applications

The landscape for pharma-grade PET/PVDC film is undergoing transformative shifts driven by technological innovation, regulatory tightening, and a renewed emphasis on circularity. Advances in coating chemistry and lamination techniques have enabled thinner constructions to deliver equivalent or superior barrier performance, which reduces material usage and can improve packaging line throughput. Simultaneously, regulatory agencies globally have increased scrutiny on extractables and leachables, forcing suppliers to refine polymer formulations and validate coating adhesion and migration profiles under accelerated aging and sterilization protocols. The convergence of these technical and regulatory pressures is accelerating adoption of hybrid solutions that blend traditional PVDC performance with alternative barrier layers when warranted by environmental or supply considerations.

At the same time, procurement and supply chain strategies are adapting. The drive to de-risk supply chains is encouraging vertical integration and nearshoring, while buyers demand suppliers demonstrate robust quality systems, lot-to-lot consistency, and traceable raw-material provenance. Sustainability imperatives are also reshaping R&D roadmaps; formulators explore SiOx and EVOH barrier layers, and converters optimize lamination processes to reduce energy consumption. Taken together, these shifts require cross-functional decision-making that aligns R&D innovation, regulatory strategy, and commercial priorities to deliver compliant, cost-effective, and environmentally conscious packaging solutions.

Understanding the cascading effects of recent tariff shifts on sourcing risk production placement and the regulatory validation burden for pharmaceutical packaging suppliers

Recent tariff developments and trade policy adjustments have introduced a new layer of complexity to supply chain planning and cost optimization for converters and pharmaceutical packaging buyers. Tariff actions influence the relative competitiveness of regional production hubs and have catalyzed near-term adjustments to sourcing strategies, even when product specifications remain the primary determinant of supplier selection. As trading costs fluctuate, manufacturers consider the total landed cost including compliance, transportation lead times, and duty exposure when structuring supply contracts. This dynamic incentivizes multi-sourcing, longer-term purchasing agreements with tariff-protection clauses, and a closer alignment between procurement and regulatory functions to ensure uninterrupted supply for critical drug packaging formats.

Moreover, tariffs have secondary consequences that affect innovation and capacity decisions. Investment in regional converting assets becomes more attractive when trade barriers elevate import costs, while research and development centers may be co-located with production for accelerated sample iteration and validation. Regulatory filings for primary packaging materials often require extensive documentation; therefore, shifting production locale can trigger additional comparability work. In sum, tariff shifts require packaging leaders to reassess vendor risk profiles, maintain flexible qualification pathways, and ensure that supply continuity plans explicitly incorporate regulatory and validation lead times alongside tariff considerations.

Deep segmentation insights into applications material architectures film form thickness bands and end-use requirements that dictate performance validation and commercial fit

Segmentation of the market by application, material type, film form, thickness, and end-use industry reveals distinct performance priorities and commercialization pathways that influence material selection and production strategy. When evaluating by application, blister packaging demands consistent thermoformability and robust seal integrity over time, whereas lidding films prioritize peel characteristics and clear, defect-free surfaces for tamper evidence; pouches require flexible multilayer constructions that balance barrier with seal strength, and sealants must deliver reliable adhesion and hermetic closure under diverse heat-sealing profiles. These divergent performance requirements shape the choice between coated films and extruded laminates, and they also determine validation protocols and in-line quality checks.

Material type introduces another layer of differentiation. Coated films typically achieve high barrier performance by applying EVOH, PVDC, or SiOx coatings onto a PET substrate, which allows converters to combine the mechanical benefits of PET with targeted gas and moisture resistance. EVOH coatings offer excellent oxygen barrier properties but require careful moisture protection to maintain performance, while PVDC coatings are prized for broad-spectrum barrier and compatibility with sterilization. SiOx coatings provide inorganic barrier layers that can reduce reliance on halogenated chemistries, but they call for meticulous handling to avoid microcracks. Extruded laminate constructions, whether produced via adhesive lamination or coextrusion, enable monolithic barrier layers and often improve recyclability pathways; adhesive lamination allows modular layer selection while coextrusion can enhance interlayer cohesion and enable thinner overall constructions.

Film form and thickness further refine application fit. Cut sheets are commonly used when discrete, pre-cut elements are required for specific blister or lidding operations and when handling and registration precision is paramount, while roll stock supports high-speed automated processes and continuous feedlines. Thickness categories-from under 60 microns to 60-80 microns and above 80 microns-affect barrier endurance, mechanical robustness, and thermoforming behavior; thinner constructions can support cycling efficiency and material savings but necessitate rigorous quality controls to prevent performance variance. Finally, end-use industry requirements meaningfully influence specification. Medical devices often need specialty coatings for sterilization compatibility and biocompatibility documentation; nutritional supplements prioritize oxygen control to preserve potency; pharmaceutical products demand validated extractables and leachables profiles for each packaging system; and veterinary products often require cost-effective, durable packaging that meets broad distribution conditions. Understanding how these segmentation dimensions interrelate enables product teams to target formulations and validation strategies that are fit-for-purpose for each commercial context.

Critical regional insights into how the Americas EMEA and Asia-Pacific differ in manufacturing priorities regulatory focus and sustainability expectations for barrier films

Regional dynamics influence material availability compliance expectations and commercialization models across the Americas, Europe Middle East & Africa, and Asia-Pacific, each presenting distinct risk-reward profiles for manufacturers and converters. In the Americas, emphasis on manufacturing efficiency and rapid scale-up supports investment in high-throughput converting lines and integrated supply relationships. Regulatory frameworks in major markets demand detailed quality documentation and lot traceability, which encourages localized inventory buffers and strategic partnerships for validated supply. The region's logistics infrastructure favors just-in-time delivery models for large contract manufacturers, but volatility in trade policy can prompt contingency planning through regional dual-sourcing.

Europe, the Middle East & Africa region emphasizes regulatory harmonization and environmental compliance, with increasing pressure to demonstrate recyclability and reduced lifecycle impacts. As a result, suppliers in this region often prioritize alternative barrier technologies and maintain robust environmental product declarations to satisfy procurement criteria. Converters here frequently invest in pilot-scale facilities to support customer-specific sustainability proofs and to expedite collaborative validation for clinical-stage pharmaceutical customers. In contrast, the Asia-Pacific region combines scale-driven manufacturing capability with rapid innovation cycles, enabling cost-competitive barrier film production and experimentation with novel coating chemistries. However, buyers must account for diverse regulatory regimes and ensure comparability and documentation are in place when qualifying suppliers from multiple jurisdictions. Each regional dynamic shapes how stakeholders approach supplier selection, qualification timelines, and investment in localized capability.

Key corporate strategies and capability investments that distinguish market leaders including innovation in coatings quality systems and collaborative commercialization models

Leading participants in the pharma-grade PET/PVDC film ecosystem demonstrate converging strategies around innovation, compliance, and vertical collaboration. Companies that succeed invest continually in coating R&D and lamination technologies to extend barrier performance while addressing sustainability objectives. These investments often manifest as pilot lines for new coating chemistries, automated inspection systems to secure consistent quality at high speed, and expanded analytical capabilities for extractables and leachables testing. Strategic partnerships between material suppliers and converters have emerged as an effective way to accelerate product qualification and reduce time to market for new packaging concepts.

Operational excellence is also a differentiator. High-performing organizations maintain rigorous quality management systems, synchronized supply chain visibility, and flexible manufacturing footprints that can shift between coated film roll stock and laminated sheet production in response to customer demand. They prioritize traceability across polymer suppliers and additive chemistries to simplify regulatory submissions and comparability protocols. Finally, commercial agility matters: vendors that combine technical application support with sample-to-scale roadmaps and validation packages tend to win strategic contracts, especially in regulated pharmaceutical segments where change control and documentation are central to qualification.

Actionable high-impact recommendations for procurement R&D and regulatory teams to secure supply innovate responsibly and accelerate compliant commercialization

Industry leaders should take immediate, measurable actions to secure supply continuity, accelerate material innovation, and align packaging portfolios with evolving regulatory and sustainability expectations. First, integrate cross-functional governance that includes procurement, regulatory affairs, and R&D to make material selection decisions based on a holistic assessment of barrier performance, validation workload, and supply risk. This alignment shortens decision cycles and reduces the probability of late-stage comparability issues. Second, diversify supplier networks to include both regional converters and specialty coaters to mitigate tariff exposure and logistics disruptions while enabling faster response for clinical and commercial launches. Third, prioritize investment in analytical and pilot-scale capabilities that validate extractables and leachables, thermal stability, and sterilization compatibility early in product development to eliminate downstream surprises.

Additionally, accelerate sustainability by pursuing barrier solutions that lower lifecycle impact without compromising compliance. This may involve evaluating SiOx or EVOH-based approaches where appropriate, optimizing lamination architectures for recyclability, and engaging with supply chain partners to document polymer provenance. Finally, build contractual flexibility into procurement to manage tariff volatility, including mechanisms for pass-through, hedging, or periodic renegotiation tied to trade policy changes. Implementing these recommendations will enhance resilience, support faster commercialization, and maintain regulatory alignment as market conditions evolve.

Transparent and reproducible research methodology combining expert primary interviews technical literature review and supply chain mapping to validate insights

The research methodology underpinning this executive summary combines a disciplined mix of primary and secondary approaches to ensure robust, actionable findings. Primary research involved structured interviews with packaging technologists, regulatory affairs specialists, and procurement leads across pharmaceutical and medical device companies to capture first-hand perspectives on material performance, validation challenges, and supplier selection criteria. Those insights were triangulated with technical discussions with coating chemists and converting engineers to verify feasibility of emergent barrier solutions and to identify operational constraints on scale-up and line integration.

Secondary research encompassed a careful review of regulatory guidance documents, technical literature on barrier materials, and industry white papers focusing on extractables and leachables, sterilization compatibility, and life cycle assessment methodologies. Data synthesis emphasized cross-validation: technical claims were compared against multiple independent sources and experimental evidence where available. The methodology also included supply chain mapping to identify single points of failure and to understand how tariff dynamics could impact lead times and qualification pathways. Together, these methods provide a defensible evidence base for the insights and recommendations offered in this document.

Concluding synthesis that reinforces the imperative for integrated technical regulatory and procurement strategies to protect product integrity and commercial resilience

In conclusion, pharma-grade PET/PVDC film strategy requires a careful balancing of barrier performance, regulatory compliance, supply resilience, and environmental responsibility. Technical innovations in coatings and lamination are enabling thinner, more efficient constructions while regulatory emphasis on extractables and lifecycle impacts compels rigorous validation and documentation. Tariff shifts have made supplier diversification and regional capability investments pragmatic considerations rather than optional strategies, and segmentation by application, material architecture, film form, thickness, and end use clarifies where performance investments yield the greatest commercial return.

Leaders who align cross-functional teams, invest in pilot-scale validation and analytical capacity, and pursue pragmatic sustainability pathways will be best positioned to deliver packaging systems that protect product integrity and meet stakeholder expectations. The path forward is not solely technical; it is organizational. Companies that operationalize the recommendations in this summary will reduce time-to-market risk, maintain regulatory compliance, and strengthen commercial resilience in a market defined by rapid technical evolution and dynamic trade environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharma-Grade PET/PVDC Film Market, by Material Type

  • 8.1. Coated Film
    • 8.1.1. EVOH Coating
    • 8.1.2. PVDC Coating
    • 8.1.3. SiOx Coating
  • 8.2. Extruded Laminate
    • 8.2.1. Adhesive Lamination
    • 8.2.2. Coextrusion

9. Pharma-Grade PET/PVDC Film Market, by Film Form

  • 9.1. Cut Sheets
  • 9.2. Roll Stock

10. Pharma-Grade PET/PVDC Film Market, by Thickness

  • 10.1. 60 To 80 Microns
  • 10.2. Above 80 Microns
  • 10.3. Under 60 Microns

11. Pharma-Grade PET/PVDC Film Market, by Application

  • 11.1. Blister Packaging
  • 11.2. Lidding Film
  • 11.3. Pouches
  • 11.4. Sealants

12. Pharma-Grade PET/PVDC Film Market, by End Use Industry

  • 12.1. Medical Devices
  • 12.2. Nutritional Supplements
  • 12.3. Pharmaceutical Products
  • 12.4. Veterinary Products

13. Pharma-Grade PET/PVDC Film Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharma-Grade PET/PVDC Film Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharma-Grade PET/PVDC Film Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharma-Grade PET/PVDC Film Market

17. China Pharma-Grade PET/PVDC Film Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amcor Plc
  • 18.6. Asahi Kasei Corporation
  • 18.7. Berry Global Group, Inc.
  • 18.8. Bilcare Limited
  • 18.9. Constantia Flexibles Group GmbH
  • 18.10. Cosmo Films Ltd.
  • 18.11. DuPont de Nemours, Inc.
  • 18.12. Honeywell International Inc.
  • 18.13. Innovia Films Ltd.
  • 18.14. Jindal Poly Films Limited
  • 18.15. Jindal Poly Films Limited
  • 18.16. Klockner Pentaplast Group
  • 18.17. Kuraray Co., Ltd
  • 18.18. Kureha Corporation
  • 18.19. Mitsubishi Chemical Corporation
  • 18.20. Mondi plc
  • 18.21. SKC Co., Ltd
  • 18.22. Toray Plastics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EVOH COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EVOH COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EVOH COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY PVDC COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY PVDC COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY PVDC COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SIOX COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SIOX COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SIOX COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ADHESIVE LAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ADHESIVE LAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ADHESIVE LAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COEXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COEXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COEXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY CUT SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY CUT SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY CUT SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ROLL STOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ROLL STOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ROLL STOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY 60 TO 80 MICRONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY 60 TO 80 MICRONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY 60 TO 80 MICRONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ABOVE 80 MICRONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ABOVE 80 MICRONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY ABOVE 80 MICRONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY UNDER 60 MICRONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY UNDER 60 MICRONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY UNDER 60 MICRONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY BLISTER PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY BLISTER PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY BLISTER PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY LIDDING FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY LIDDING FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY LIDDING FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY PHARMACEUTICAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY PHARMACEUTICAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY PHARMACEUTICAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY VETERINARY PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY VETERINARY PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY VETERINARY PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 146. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 148. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 170. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 172. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. G7 PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 178. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 180. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 181. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY COATED FILM, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY EXTRUDED LAMINATE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY FILM FORM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA PHARMA-GRADE PET/PVDC FILM MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)